Published in AIDS Weekly, January 20th, 2003
Working at Ogikubo Hospital in Tokyo, Hideji Hanabusa assessed the efficacy of high-dose IFN therapy in hemophiliacs coinfected with HIV and HCV.
A group of 30 patients - 15 coinfected with HIV and HCV and 15 age-matched patients infected with HCV alone - received high-dose IFN-alpha2a therapy for 24 weeks. HIV viral loads dropped from roughly 7410...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.